Showing results (361-370 of 388) with videos related to
Sort By:
Pageof 39
Journal of Clinical Lipidology|April 13, 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid AssociationDinesh Kalra, Krishnaswami Vijayaraghavan, Geeta Sikand, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2015
Mapping the Binding Site of a Cross-Reactive Plasmodium falciparum PfEMP1 Monoclonal Antibody Inhibitory of ICAM-1 BindingFrank Lennartz, Anja Bengtsson, Rebecca W Olsen, et al.International Journal of Toxicology|January 21, 2026
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based TherapeuticsJennifer D Sisler, Patrik Andersson, Alan Brown, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2012
A novel domain cassette identifies Plasmodium falciparum PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodiesAnja Bengtsson, Louise Joergensen, Thomas S Rask, et al.Glycobiology|June 21, 2007
Influence of substitution pattern and cation binding on conformation and activity in heparin derivativesTimothy R Rudd, Scott E Guimond, Mark A Skidmore, et al.Contemporary Clinical Trials|January 15, 2026
Remote delivery of a mindfulness-based intervention for adults with tics: Protocol of a randomized controlled trialHannah E Reese, W Alan Brown, Yaerin H Wallenberger, et al.Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.Cell|June 16, 2023
Structural specializations of the sperm tailMiguel Ricardo Leung, Jianwei Zeng, Xiangli Wang, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Sulfonamides as selective oestrogen receptor β agonistsLee R Roberts, Duncan Armor, Carolyn Barker, et al.Pilot and Feasibility Studies|February 7, 2017
Rapid analgesia for prehospital hip disruption (RAPID): protocol for feasibility study of randomised controlled trialJenna K Bulger, Alan Brown, Bridie A Evans, et al.Pageof 39